// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
With significant innovations in pharmaceuticals, including biologic drugs
Over the past three decades, our medicines have become increasingly “globalized.” In the US alone
Desmond Hunt, Ph.D., USP’s Senior Scientific Liaison, provides insight into packaging